004080.KO Shinhung
- Market cap
- KRW 134B
- P/E
- 25.0x
- P/B
- 1.15x
- ROE
- 8.1%
- Dividend yield
- 1.92%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 004080.KO undervalued?
Graham number004080.KO trades 13.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shinhung fundamental analysis
No fundamental analysis for Shinhung yet.
Shinhung stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shinhung
Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory products; and disposable needles, dental operatories, and autoclaves and X-ray eq…
Full company profileShinhung financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shinhung annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 124B | 121B | 122B | 123B | 117B | 127B | 118B | 112B | 102B | 103B | 103B |
| Gross Profit | 31.6B | 31.4B | 29.5B | 30.7B | 30.0B | 37.0B | 34.8B | 36.0B | 30.9B | 31.9B | 34.1B |
| Operating Income | 4.23B | 4.03B | 1.11B | 3.00B | 3.16B | 13.0B | 10.5B | 11.4B | 6.28B | 7.09B | 8.90B |
| EBITDA | - | 8.81B | 8.90B | 6.33B | 20.5B | 23.6B | 13.6B | 15.3B | 10.8B | 9.27B | 12.5B |
| Net Income | 1.16B | 3.17B | 3.05B | 2.04B | 12.4B | 13.4B | 8.46B | 9.23B | 5.23B | 2.82B | 9.41B |
| EPS | - | 332 | 320 | 214 | 1,302 | 1,430 | 903 | 978 | 553 | 299 | 1,013 |
| Balance Sheet | |||||||||||
| Total Assets | 132B | 131B | 133B | 147B | 146B | 139B | 141B | 140B | 141B | 150B | 157B |
| Total Liabilities | 46.8B | 44.9B | 45.4B | 58.7B | 54.3B | 37.2B | 33.8B | 26.4B | 25.3B | 33.6B | 39.9B |
| Shareholders' Equity | 84.6B | 86.4B | 87.3B | 88.0B | 91.9B | 101B | 107B | 114B | 116B | 115B | 117B |
| Cash & Short-term Investments | 198M | 184M | 320M | 341M | 120M | 5.78B | 2.73B | 2.53B | 1.38B | 1.60B | 1.61B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.17B | 2.55B | 1.98B | 908M | 12.8B | 3.34B | 4.42B | 7.64B | 9.58B | 1.93B | -3.34B |
| Capital Expenditure | 845M | 1.02B | 3.56B | 16.2B | 20.3B | 1.98B | 3.46B | 5.98B | 3.94B | 3.52B | 3.25B |
| Free Cash Flow | - | 1.22B | -2.07B | -15.3B | -7.60B | 974M | 960M | 1.66B | 5.65B | -1.59B | -6.59B |
| Ratios | |||||||||||
| ROE | 1.4% | 3.7% | 3.5% | 2.3% | 13.5% | 13.3% | 7.9% | 8.1% | 4.5% | 2.4% | 8.1% |
| ROA | 0.9% | 2.4% | 2.3% | 1.4% | 8.5% | 9.7% | 6.0% | 6.6% | 3.7% | 1.9% | 6.0% |
| Net Profit Margin | 0.9% | 2.6% | 2.5% | 1.7% | 10.7% | 10.6% | 7.2% | 8.2% | 5.1% | 2.8% | 9.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Shinhung dividends
- Dividend yield
- 1.92%
- Forward dividend
- 360.00 KRW
- Payout ratio
- 91.0%
- Ex-dividend date
- Jun 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 2.57B | 272 | 91.0% |
| 2024 | KRW 2.50B | 264 | 47.8% |
| 2023 | KRW 2.45B | 259 | 26.5% |
| 2022 | KRW 2.25B | 240 | 26.6% |
| 2021 | KRW 1.90B | 203 | 14.2% |
| 2020 | KRW 1.15B | 120 | 9.2% |
| 2019 | KRW 1.15B | 120 | 56.1% |
| 2018 | KRW 1.15B | 121 | 37.7% |
| 2017 | KRW 1.15B | 121 | 36.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Jul 26, 1999.
Who owns Shinhung
- Insiders 81.57%
- Institutions 0.03%
- Public & others 18.40%
- Shares outstanding 9.24M
- Free float 1.15M
Shinhung company profile
- Company name
- Shinhung
- Ticker
- 004080.KO
- ISIN
- KR7004080008
- Exchange
- Korea Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 188
- Fiscal year end
- December
- Address
- Shinhung Building, Seoul, South Korea, 04510
- Phone
- 82 2 6366 2122
- Website
- shinhung.co.kr
About Shinhung
Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory products; and disposable needles, dental operatories, and autoclaves and X-ray equipment. The company also offers loan services for dentists. Shinhung Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Shinhung management
4- Mr. Yeung-Kyu LeeFounder and Chairman · born 1930
- Mr. Yong-Ik YiChief Executive Officer, President and Director · born 1956
- Ki-Hwan ChoiSenior Managing Director and Director · born 1954
- Yong-Hun LeeManaging Director and Director · born 1958